#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma refractory Selective polysaccharide antibody deficiency Cataract Hypoxic-ischaemic encephalopathy Neoplasm Prodromal Alzheimer's disease Myeloid leukaemia Infection in an immunocompromised host Osteogenesis imperfecta Transitional cell cancer of the renal pelvis and ureter Pancreatic carcinoma Cytomegalovirus infection Oesophageal achalasia Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Sarcoidosis More trials…

    Learn about Rare Diseases

    Pleomorphic leiomyosarcoma – Basic Information Nephrotic syndrome – Basic Information Pulmonary sarcoidosis – Trials in Disease Hereditary ataxia – Treatment Encephalitis autoimmune – Diagnostics Pelizaeus-Merzbacher disease – Diagnostics Rhabdomyosarcoma recurrent – Basic Information Castleman’s disease – Basic Information Glomerulonephritis membranoproliferative – Life with Disease Rosai-Dorfman syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pemafibrate OMTX705 Jk08 Dyp688 Tecaginlimab Sodium Hypochlorite Rtx001 Linaclotide LY3537021 POTASSIUM HYDROXIDE Benztropine Mesylate A49 Lysine Aspirin Pervi-Fus Pamapimod Etoposide Imidapril Hydrochloride Sitagliptin ULEFNERSEN Rotigotine More therapies…

    Learn about Your Condition

    Papilloma viral infection Hepatitis D Angiosarcoma non-metastatic Choroidal neovascularisation Palpitations Otitis media Nephrogenic anaemia Immune-mediated renal disorder Malignant melanoma Cutaneous calcification Primary myelofibrosis Kearns-Sayre syndrome Coeliac disease Polymyalgia rheumatica Herpes virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eosinophilic oesophagitis

  • Study on Budesonide Tablets for Treating Eosinophilic Esophagitis in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Budesonide
    Austria Germany Portugal Spain

  • Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Fluticasone Propionate
    • Tetracosactide
    The Netherlands

  • Study on BP1.7881 for Adults with Eosinophilic Esophagitis

    Recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Bp1.7881A
    France Italy

  • Dupilumab Maintenance Dose Optimization in Adults with Eosinophilic Esophagitis: A Randomized Controlled Non‑Inferiority Study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Dupilumab
    The Netherlands

  • Study on the Use of Viscous Budesonide for Children with Eosinophilic Esophagitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Budesonide
    Italy

  • Study on Etrasimod Arginine for Patients with Ulcerative Colitis, Alopecia Areata, Atopic Dermatitis, and Eosinophilic Esophagitis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    • Alopecia areata
    • Colitis ulcerative
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!